TP73 and endometrial cancer: Our immunoblotting and immunocytochemistry data suggest that SETD8 knockdown with siRNA or a SETD8-selective inhibitor in endometrial cancer cell lines led to a decrease in H4K20 methylation, an increase in TP73 expression, and ultimately, apoptosis.